Arrythmia-Mediated Valvular Heart Disease

Sébastien Deferm; Philippe B Bertrand; Sebastiaan Dhont; Ralph S von Bardeleben; Pieter M Vandervoort

doi:10.1016/j.hfc.2023.02.008

Arrythmia-Mediated Valvular Heart Disease

Heart Fail Clin. 2023 Jul;19(3):357-377. doi: 10.1016/j.hfc.2023.02.008. Epub 2023 Apr 14.

Authors

Sébastien Deferm¹, Philippe B Bertrand², Sebastiaan Dhont³, Ralph S von Bardeleben⁴, Pieter M Vandervoort⁵

Affiliations

¹ Hasselt University, Agoralaan Building D, 3590 Diepenbeek, Belgium; Department of Cardiology, Mainz University Hospital, Langenbeckstraße 1, Mainz, Germany. Electronic address: https://twitter.com/S_Deferm.
² Hasselt University, Agoralaan Building D, 3590 Diepenbeek, Belgium; Department of Cardiology, Hospital Oost-Limburg Genk, Schiepse Bos 6, 3600 Genk, Belgium. Electronic address: https://twitter.com/Ph_Bertrand.
³ Hasselt University, Agoralaan Building D, 3590 Diepenbeek, Belgium; Department of Cardiology, Hospital Oost-Limburg Genk, Schiepse Bos 6, 3600 Genk, Belgium. Electronic address: https://twitter.com/S_Dhont.
⁴ Department of Cardiology, Mainz University Hospital, Langenbeckstraße 1, Mainz, Germany. Electronic address: https://twitter.com/vonbardelebenRS.
⁵ Hasselt University, Agoralaan Building D, 3590 Diepenbeek, Belgium; Department of Cardiology, Hospital Oost-Limburg Genk, Schiepse Bos 6, 3600 Genk, Belgium. Electronic address: pieter.vandervoort@zol.be.

PMID: 37230650
DOI: 10.1016/j.hfc.2023.02.008

Abstract

The aging population is rising at record pace worldwide. Along with it, a steep increase in the prevalence of atrial fibrillation and heart failure with preserved ejection fraction is to be expected. Similarly, both atrial functional mitral and tricuspid regurgitation (AFMR and AFTR) are increasingly observed in daily clinical practice. This article summarizes all current evidence regarding the epidemiology, prognosis, pathophysiology, and therapeutic options. Specific attention is addressed to discern AFMR and AFTR from their ventricular counterparts, given their different pathophysiology and therapeutic needs.

Keywords: Atrial fibrillation; Atrial functional mitral regurgitation; Atrial functional tricuspid regurgitation; Atrial myopathy; Functional mitral regurgitation; Heart failure with preserved ejection fraction; Isolated tricuspid regurgitation; Left atrium.

Publication types

Review

MeSH terms

Aged
Atrial Fibrillation* / epidemiology
Heart Atria
Heart Valve Diseases* / complications
Heart Valve Diseases* / epidemiology
Humans
Mitral Valve Insufficiency* / epidemiology
Mitral Valve Insufficiency* / etiology
Prognosis